Willingness to accept and willingness to pay for a COVID-19 vaccine booster shot in Thailand
Article Sidebar
Main Article Content
Abstract
Background: COVID-19 is an emerging disease that require urgent vaccination. The government provided COVID-19 vaccination for the population, but some residents did not accept this vaccine. Therefore, they preferred to choose and pay for the vaccination themselves.
Objectives: This study aimed to determine 1) factors associated with acceptance of the COVID-19 vaccine and vaccine booster shots, 2) reasons and willingness to pay for the COVID-19 vaccine and vaccine booster shots, and 3) the policy recommendation for COVID-19 vaccination in Thailand.
Methods: This study was conducted in 3 phases. Phase 1 is investigating the factors of vaccine acceptance. The total sample consisted of 1,740 individuals. Data analysis were carried out using descriptive statistic and multiple logistic regression. Phase 2 is associated with exploring the reasons and willingness to pay for the COVID-19 vaccine and vaccine booster shots. Phase 3 is about policy recommendations for the vaccination campaign. The data analysis used for this phase was content analysis.
Results: Factors related to the willingness to accept the COVID-19 vaccine and vaccine booster shots were 1) an intention to take the vaccine, 2) vaccine efficacy, 3) attitudes toward the COVID-19 vaccine, 4) some doses of the COVID-19 vaccine, 5) age, 6) area of residence, 7) having an influenza vaccination history, 8) medical personnel, and 9) income. Reasons for receiving the COVID 19 vaccine were protecting themselves (76.67%). The main reason for refusing the COVID-19 vaccine was negative news on vaccines. The willingness to pay for a vaccine ranged from 500-999 Thai Baht.
Conclusions: Policy recommendations should focus on unbiased media, vaccine distribution equity and a vaccine campaign by and age group priority.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับวิทยาลัยพยาบาลบรมราชชนนี จังหวัดนนทบุรี และคณาจารย์ท่านอื่น ในวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
References
WHO. Director-General’s opening remarks at the media briefing on COVID-19. [internet]. 2020. [cited 2021 Mar 20]; Available from: https://www.who.int/director-general/speeches/ detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612-21. doi: 10. 1080/21645515.2020.1846397.
Robinson E, Jones A, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024-34. doi: 10. 1016/j.vaccine.2021.02.005.
Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194: 245-51. doi: 10.1016/j.puhe.2021.02.025.
Department of Disease. Control, Ministry of Public Health. Thailand's COVID-19 vaccine. [internet]. 2021 [cited 2021 May 31]; Available from: https://ddcmoph.go.th/ vaccine-covid19/.
Ajzen, I. The theory of planned behavior. Organ Behav Decis Process. 1991;50(2): 179-211. doi: 10.1016/0749-5978(91)90020-T.
Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623-34. doi: 10.1002/(sici) 1097-0258(19980730)17:14<1623::aid-sim871>3.0.co;2-s.
Kamis A, Zhang Y, Kamis T. A multiyear model of influenza vaccination in the United States. Int J Environ Res Public Health. 2017;14(8):849. doi: 10.3390/ijerph 14080849.
Carlin JB, Hocking J. Design of cross-sectional surveys using cluster sampling: an overview with Australian case studies. Aust N Z J Public Health. 1999;23(5):546-51. doi: 10.1111/j.1467-842x.1999. tb01317.x.
Wejnert C, Pham H, Krishana N, Le B, Dinenno E. Estimating design effect and calculating sample size for respondent-driven sampling studies of injection drub users in the Unied Strates. AIDS Behav. 2012;16(4):797-806. doi: 10.1007/s10461-012-0147-8.
Wake AD. The willingness to receive COVID-19 vaccine and its associated factors: "vaccination refusal could prolong the war of this pandemic" A systematic review. Risk Manag Healthc Policy. 2021;14: 2609–23. doi: 10.2147/ RMHP.S311074.
Maltezou HC, Pavli A, Dedoukou X, Georgakopoulou T, Raftopoulos V, Drositis I, et al. Determinants of intention to get vaccinated against COVID-19 among healthcare personnel in hospitals in Greece. Infect Dis Health. 2021;26(3):189-97. doi: 10.1016/j.idh.2021.03.002.
Sonawane K, Troisi CL, Deshmukh AA. COVID-19 vaccination in the UK: Addressing vaccine hesitancy. Lancet Reg Health Eur. 2021;1:100016. doi:101016/j.lanepe.2020. 100016.
Alqudeimat Y. Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, et al. Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait. Med Princ Pract. 2021;30(3):262-71. doi: 10.1159/ 000514636.
Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Kalanidhi KB, et al. What Indians think of the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic analysis. Diabetes Metab Syndr. 2021;15(3):679-82. doi: 10.1016/j.dsx.2021.03.021.
Coe BA. Elliott MH, Gatewood SBS, Goode JR, Moczygemba LR.Perceptions and predictors of intention to receive the COVID-19 vaccine. Res Social Adm Pharm. 2022;18(4):2593-9. doi. 10. 1016/j.sapharm. 2021.04.023.
Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A, Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic, Vaccine. 2020;38(45):7002-6. doi: 10.1016/j.vaccine.2020.09.041.
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. doi.10.1016/j.lanepe. 2020.100012.
Cerda AA, García LY. Willingness to pay for a COVID-19 vaccine. Appl Health Econ Health Policy. 2021;19(3):343-51. doi: 10. 1007/s40258-021-00644-6.
Catma S, Varol S. Willingness to pay for a hypothetical COVID-19 vaccine in the United States: A contingent valuation approach. Vaccines (Basel). 2021;9(4):318. doi: 10.3390/vaccines9040318.
Goruntla N, Chintamani SH, Bhanu P, Samyuktha S, Veerabhadrappa KV, Bhupalam P, et al. Predictors of acceptance and willingness to pay for the COVID-19 vaccine in the general public of India: A health belief model approach. Asian Pac J Trop Med. 2021;14(4):165-75. doi: 10.4103/1995-7645.312512.
